Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Beurs gesloten - NYSE 22:00:00 30-07-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2,990 USD +4,18% Intraday-grafiek van Perspective Therapeutics, Inc. +1,36% +8,73%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+4,18%+1,36%-12,32%-23,33%+8,73%-22,94%-49,32%-56,43%-61,17% 327 mln.
-0,80%+5,16%+4,47%+18,99%+6,02%-0,70%+13,00%-19,14%+212,10% 48,95 mld.
-3,95%+14,70%+23,07%+50,15%+5,49%+24,15%+5,15%-4,00%+206,27% 40,75 mld.
+6,22%+1,81%+2,61%+33,34%+141,27%+419,17%+647,45%+570,98% - 38,46 mld.
-1,57%-1,44%+13,02%+9,08%+6,01%+7,38%+43,06%+1,73%+1.127,44% 36,38 mld.
+5,56%+11,70%+6,03%-2,21%+10,22%+11,64%+51,50%-11,63%+159,73% 28,45 mld.
-0,39%-0,63%-5,87%+9,46% - - - - - 16,62 mld.
-1,13%-4,54%+9,20%+38,13%+2,96%+32,10%+126,95%+228,69% - 16,33 mld.
-7,10%-2,81%-4,71%+39,89%-9,16%-8,80%-34,35%-31,96%+113,12% 13,65 mld.
-0,06%+3,75%+0,06%+16,23%+9,94%+3,81%+10,08%-31,97%+104,50% 13,56 mld.
-0,08%+2,32%+3,45%+40,52%+17,62%+33,16%+11,46%-42,34%+166,83% 11,31 mld.
0,00%+0,36%+1,95%+30,21%+22,48%+24,81%-14,04%-40,25%+156,29% 11,22 mld.
+0,09%-5,24%-6,06%+12,49%-9,88%+75,57%+517,88%+261,06%+2.514,46% 10,63 mld.
+0,07%+0,03%+1,18%+62,02%+77,93%+257,09%+547,23% - - 10,08 mld.
-3,25%-7,67%+24,47%+22,86%+26,66%+11,90%+37,29%-59,07% - 9,18 mld.
-1,41%-4,64%-32,80%-28,73%-32,65%+22,85%+33,90%+43,46%+82,53% 8,93 mld.
+1,67%-3,05%-6,68%+32,00%+37,53%+142,82%+389,97%+77,82% - 8,66 mld.
-0,86%0,00%+6,01%+19,87%-12,44%-22,13%-21,19%-29,65%+33,43% 8,65 mld.
+4,24%+2,37%+13,10%+40,08%+58,74%+153,83%+626,24%+180,48% - 8,55 mld.
+5,75%-4,54%-8,08%-3,48%+4,41%+443,82%+1.993,54%+31,52% - 8,11 mld.
Gemiddelde +0,36%+2,07%+1,61%+20,88%+19,57%+84,71%+259,78%+59,40%+401,29% 17,44 mld.
Gewogen gemiddelde per kap. +0,19%+5,01%+5,36%+23,89%+25,18%+85,63%+201,30%+84,90%+423,92%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.